1. Home
  2. RCG vs CODX Comparison

RCG vs CODX Comparison

Compare RCG & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RCG

RENN Fund Inc

HOLD

Current Price

$2.63

Market Cap

18.1M

Sector

Finance

ML Signal

HOLD

Logo Co-Diagnostics Inc.

CODX

Co-Diagnostics Inc.

HOLD

Current Price

$2.74

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCG
CODX
Founded
1994
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
15.6M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RCG
CODX
Price
$2.63
$2.74
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$67.50
AVG Volume (30 Days)
5.9K
82.5K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
0.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$507,892.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.52
$4.84
52 Week High
$1.90
$46.50

Technical Indicators

Market Signals
Indicator
RCG
CODX
Relative Strength Index (RSI) 55.08 51.42
Support Level $2.53 $0.17
Resistance Level $2.65 $6.35
Average True Range (ATR) 0.09 0.57
MACD 0.00 0.27
Stochastic Oscillator 93.33 42.25

Price Performance

Historical Comparison
RCG
CODX

About RCG RENN Fund Inc

RENN Fund Inc is active in the financial services domain. It is a a registered, non-diversified, closed-end management investment company formed to provide return through capital appreciation and income by a long-term, value-oriented investment process that invests in a wide variety of financial instruments, including but not limited to, common stocks, fixed-income securities including convertible and non-convertible debt securities or loans, distressed debt, warrants, and preferred stock, exchange-traded funds and exchange-traded notes, and other instruments. It invests in various industries, including communication services, surgical and medical instruments and apparatus, oil and gas, medical chemicals, botanical products, etc.

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Share on Social Networks: